Screener
Chemed CHE Ratios & Valuation
| Q2 '26 | Q1 '26 | Q4 '25 | Q3 '25 | Q2 '25 | ||
|---|---|---|---|---|---|---|
| Profitability | ||||||
| Gross margin | 33.1%-0.5pp | 32.4%-2.4pp | 32.5%-2.6pp | 32.9%-2.8pp | 33.6%-2.3pp | |
| Operating margin | 13.5%-1.2pp | 12.9%-2.7pp | 13.4%-1.7pp | 13.9%-1.4pp | 14.7%-0.7pp | |
| Net margin | 10.6%-1.0pp | 10.2%-2.2pp | 10.5%-1.9pp | 11%-1.7pp | 11.6%-1.3pp | |
| Returns | ||||||
| Return on equity | 27.1%+3.0pp | 25.6%-0.5pp | 25.3%-1.8pp | 24.1%-2.6pp | 24.1%-3.7pp | |
| Return on invested capital | 31.2%+2.9pp | 25.1%-5.4pp | 27%-3.4pp | 27%-2.1pp | 28.3%-1.6pp | |
| Efficiency | ||||||
| Asset turnover | 1.6×+0.1× | 1.6×+0.1× | 1.6×+0.1× | 1.5×+0.1× | 1.5×0.0× | |
| Liquidity | ||||||
| Current ratio | 0.9×-1.0× | 0.9×-0.9× | 1.1×-0.3× | 1.4×-0.5× | 1.9×+0.1× | |
| Leverage | ||||||
| Debt-to-equity | 0.2×+0.1× | 0.3×+0.2× | 0.1×0.0× | 0.1×0.0× | 0.1×0.0× | |
| Valuation | ||||||
| Market capitalization | $7.18B+14.9% | $5.2B-42.3% | $6.04B-24.0% | $6.52B-28.1% | $8.15B-0.6% | |
| Price / earnings | 26.1×+4.6× | 20×-9.2× | 22.8×-3.5× | 23.4×-6.7× | 28.1×+0.8× | |
| Price / sales | 2.8×+0.3× | 2×-1.6× | 2.4×-0.9× | 2.6×-1.2× | 3.2×-0.3× | |
| Price / book | 8.6×+3.4× | 6.1×-1.5× | 6.2×-0.9× | 6.1×-1.3× | 6.8×0.0× | |
| Dividend yield | 0.5%0.0pp | 0.6%+0.3pp | 0.5%+0.2pp | 0.5%+0.2pp | 0.4%+0.1pp |
FAQ
- What are Chemed's profit margins?
- Chemed (CHE) runs a 33.1% gross margin and a 13.5% operating margin, with a 10.6% net margin.
- Where do Chemed's ratios come from?
- Every ratio is computed from Chemed's SEC filings — trailing-twelve-month flows over period-end balances. Valuation multiples combine those fundamentals with market data, recomputed each period. Switch between quarterly, annual, and TTM, or open any ratio for its full history and peer comparisons.
